Investor Carmignac Gestion
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Carmignac Gestion . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-02-13 13G/A CLSD / Clearside Biomedical, Inc. 3,124,252 2,400,344
2022-02-09 13G/A CLSD / Clearside Biomedical, Inc. 3,540,961 3,124,252
2021-02-12 13G CLSD / Clearside Biomedical, Inc. 3,540,961
2019-02-13 13G/A GRUB / Just Eat Takeaway.com N.V. - ADR (New) 5,261,716 2,485,816
2019-02-13 13G/A MELI / MercadoLibre, Inc. 2,308,664 952,452
2018-02-06 13G/A MELI / MercadoLibre, Inc. 2,383,523 2,308,664
2018-02-06 13G/A ICPT / Intercept Pharmaceuticals Inc 2,022,792 0
2018-02-06 13G GRUB / Just Eat Takeaway.com N.V. - ADR (New) 5,261,716
2017-02-07 13G/A BSMX / Banco Santander Mexico S.A. - ADR 222,612,290 103,770,135
2017-02-07 13G MELI / MercadoLibre, Inc. 2,383,523
2017-02-07 13G/A ICPT / Intercept Pharmaceuticals Inc 1,319,887 2,022,792
2016-02-09 13G/A BSMX / Banco Santander Mexico S.A. - ADR 222,612,290
2016-02-09 13G/A GRPN / Groupon, Inc. 0 0
2016-02-09 13G/A ICPT / Intercept Pharmaceuticals Inc 1,319,887
2015-02-09 13G/A BSMX / Banco Santander Mexico S.A. - ADR 217,249,670
2015-02-09 13G GRPN / Groupon, Inc. 47,255,034
2015-02-09 13G ICPT / Intercept Pharmaceuticals Inc 1,432,071
2014-02-14 13G BSMX / Banco Santander Mexico S.A. - ADR 179,996,220